Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression

Naonori Kawakubo, Yui Harada, Minori Ishii, Ryota Sozaki, Yoshiaki Kinoshita, Tatsuro Tajiri, Tomoaki Taguchi, Yoshikazu Yonemitsu

Research output: Contribution to journalArticle

Abstract

The mechanism underlying the spontaneous regression of neuroblastoma is unclear. Although it was hypothesized that this regression occurs via an immunological mechanism, there is no clinical evidence, and no animal models have been developed to investigate the involvement of immune systems, especially natural antibodies, against neuroblastoma. We performed an immunological analysis of homo- and heterozygous TH-MYCN transgenic mice as a model of aggressive neuroblastoma. Mice with no or small (<5 mm) tumors showed higher antibody titers in plasma than mice with large (>5 mm) tumors. A significant negative correlation was observed between the tumor diameter and the titer of antitumor antibody. This antibody had complement-dependent cytotoxicity but not antibody-dependent cellular cytotoxicity against neuroblastoma cells. Moreover, B-cell depletion had no effect on the tumor incidence in vivo. We revealed that TH-MYCN transgenic mice have a natural antibody against neuroblastoma that correlate with tumor size. However, this antibody does not correlate with the spontaneous regression of neuroblastoma. Thus, the function of the natural antibody is limited.

Original languageEnglish
Pages (from-to)1666-1673
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume503
Issue number3
DOIs
Publication statusPublished - Sep 10 2018

Fingerprint

Neuroblastoma
Transgenic Mice
Antibodies
Tumors
Cytotoxicity
Neoplasms
Immune system
Immune System
Animals
B-Lymphocytes
Animal Models
Cells
Incidence

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression. / Kawakubo, Naonori; Harada, Yui; Ishii, Minori; Sozaki, Ryota; Kinoshita, Yoshiaki; Tajiri, Tatsuro; Taguchi, Tomoaki; Yonemitsu, Yoshikazu.

In: Biochemical and Biophysical Research Communications, Vol. 503, No. 3, 10.09.2018, p. 1666-1673.

Research output: Contribution to journalArticle

@article{45370b7fc8164255b8c95850f1a5c9a3,
title = "Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression",
abstract = "The mechanism underlying the spontaneous regression of neuroblastoma is unclear. Although it was hypothesized that this regression occurs via an immunological mechanism, there is no clinical evidence, and no animal models have been developed to investigate the involvement of immune systems, especially natural antibodies, against neuroblastoma. We performed an immunological analysis of homo- and heterozygous TH-MYCN transgenic mice as a model of aggressive neuroblastoma. Mice with no or small (<5 mm) tumors showed higher antibody titers in plasma than mice with large (>5 mm) tumors. A significant negative correlation was observed between the tumor diameter and the titer of antitumor antibody. This antibody had complement-dependent cytotoxicity but not antibody-dependent cellular cytotoxicity against neuroblastoma cells. Moreover, B-cell depletion had no effect on the tumor incidence in vivo. We revealed that TH-MYCN transgenic mice have a natural antibody against neuroblastoma that correlate with tumor size. However, this antibody does not correlate with the spontaneous regression of neuroblastoma. Thus, the function of the natural antibody is limited.",
author = "Naonori Kawakubo and Yui Harada and Minori Ishii and Ryota Sozaki and Yoshiaki Kinoshita and Tatsuro Tajiri and Tomoaki Taguchi and Yoshikazu Yonemitsu",
year = "2018",
month = "9",
day = "10",
doi = "10.1016/j.bbrc.2018.07.097",
language = "English",
volume = "503",
pages = "1666--1673",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Natural antibody against neuroblastoma of TH-MYCN transgenic mice does not correlate with spontaneous regression

AU - Kawakubo, Naonori

AU - Harada, Yui

AU - Ishii, Minori

AU - Sozaki, Ryota

AU - Kinoshita, Yoshiaki

AU - Tajiri, Tatsuro

AU - Taguchi, Tomoaki

AU - Yonemitsu, Yoshikazu

PY - 2018/9/10

Y1 - 2018/9/10

N2 - The mechanism underlying the spontaneous regression of neuroblastoma is unclear. Although it was hypothesized that this regression occurs via an immunological mechanism, there is no clinical evidence, and no animal models have been developed to investigate the involvement of immune systems, especially natural antibodies, against neuroblastoma. We performed an immunological analysis of homo- and heterozygous TH-MYCN transgenic mice as a model of aggressive neuroblastoma. Mice with no or small (<5 mm) tumors showed higher antibody titers in plasma than mice with large (>5 mm) tumors. A significant negative correlation was observed between the tumor diameter and the titer of antitumor antibody. This antibody had complement-dependent cytotoxicity but not antibody-dependent cellular cytotoxicity against neuroblastoma cells. Moreover, B-cell depletion had no effect on the tumor incidence in vivo. We revealed that TH-MYCN transgenic mice have a natural antibody against neuroblastoma that correlate with tumor size. However, this antibody does not correlate with the spontaneous regression of neuroblastoma. Thus, the function of the natural antibody is limited.

AB - The mechanism underlying the spontaneous regression of neuroblastoma is unclear. Although it was hypothesized that this regression occurs via an immunological mechanism, there is no clinical evidence, and no animal models have been developed to investigate the involvement of immune systems, especially natural antibodies, against neuroblastoma. We performed an immunological analysis of homo- and heterozygous TH-MYCN transgenic mice as a model of aggressive neuroblastoma. Mice with no or small (<5 mm) tumors showed higher antibody titers in plasma than mice with large (>5 mm) tumors. A significant negative correlation was observed between the tumor diameter and the titer of antitumor antibody. This antibody had complement-dependent cytotoxicity but not antibody-dependent cellular cytotoxicity against neuroblastoma cells. Moreover, B-cell depletion had no effect on the tumor incidence in vivo. We revealed that TH-MYCN transgenic mice have a natural antibody against neuroblastoma that correlate with tumor size. However, this antibody does not correlate with the spontaneous regression of neuroblastoma. Thus, the function of the natural antibody is limited.

UR - http://www.scopus.com/inward/record.url?scp=85054174184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054174184&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2018.07.097

DO - 10.1016/j.bbrc.2018.07.097

M3 - Article

VL - 503

SP - 1666

EP - 1673

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 3

ER -